A proposed global coalition

We unite the people building the future of congenital heart care.

GCHDA is the central global platform connecting device makers, AI innovators, clinicians, regulators, and investors — accelerating commercialization for the 1 in 100 born with congenital heart disease, and the millions living with it for life.

1 in 100
Births affected by CHD
90%+
Now survive into adulthood
9+
Fragmented innovation sectors
0
Global commercialization bodies — until now
Pediatric cardiologist with young patient

Our mission

Closing the gap between breakthrough technology and the children who need it.

Despite rapid advances in structural heart interventions, AI-enabled imaging, pediatric therapeutics, and minimally invasive technology, congenital cardiovascular innovation remains under-served — fragmented across pediatric cardiology, ACHD, devices, regulatory pathways, and capital.

GCHDA exists to be the unifying ecosystem — accelerating development, commercialization, and global adoption of the technologies that will transform lifelong congenital cardiovascular care.

Read the executive brief

Four strategic objectives

What an industry coalition can unlock.

All programs

Build the ecosystem

A central collaboration platform for device makers, AI innovators, hospitals, researchers, and capital.

Accelerate commercialization

Regulatory guidance, market access, clinical partnerships, procurement and reimbursement navigation.

Advocate for the sector

Pediatric innovation incentives, trial modernization, harmonization and real-world evidence frameworks.

Set shared standards

Registries, interoperability, working groups, and clinical-commercial partnerships.

Innovation summit collaboration

Flagship programs

The convening platform CHD has been missing.

  • Global Congenital Innovation Summit

    Cardiologists, founders, AI companies, regulators and investors — one room, once a year.

  • Regulatory & Market Access Council

    FDA, EMA and Health Canada pathways, pediatric approvals, HTA and reimbursement working groups.

  • Innovation Accelerator

    KOL matchmaking, hospital pilots, commercialization mentorship and venture readiness for startups.

  • Congenital Innovation Registry

    Shared outcomes data, real-world evidence, and AI-ready datasets for multi-center collaboration.

Explore programs

Founding coalition · 2026

Help shape the organization the congenital sector needs.

We are recruiting founding members, advisory council partners, and anchor sponsors across industry, clinical leadership, and capital. The first cohort defines the standards.

3D-printed heart model with imaging software